What is the address of INNOVATION 39?

The registered office of INNOVATION 39 is located at Drève d'Argenteuil 39, 1410 Waterloo.

Is INNOVATION 39 still active?

Yes. According to the CBE (29 October 2026) INNOVATION 39 is active, legal situation “Normale toestand”, started on 14 September 2015.

Is INNOVATION 39 registered on Peppol?

Yes, INNOVATION 39 is registered on the Peppol network with ID 0208:0637728676.

What is the enterprise number of INNOVATION 39?

The enterprise number of INNOVATION 39 is BE0637728676.

When was INNOVATION 39 founded?

INNOVATION 39 was founded on 14 September 2015.

Who are the directors of INNOVATION 39?

According to the 2025 annual accounts, the directors of INNOVATION 39 are: Eric FESLER.

Is INNOVATION 39 a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 September 2015; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did INNOVATION 39 make in 2025?

INNOVATION 39 posted a profit after taxes of € 22,570 in financial year 2025.

What is the revenue of INNOVATION 39?

As a small company, INNOVATION 39 is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 32,307.

INNOVATION 39 (Private Limited) - Waterloo - BE0637728676

Q: What does INNOVATION 39 do?

INNOVATION 39 is registered with the CBE as active in: Vervaardiging van meet-, controle- en navigatie-instrumenten en -apparatuur. Private Limited, started on 14 September 2015, 1 establishment.

Dossier INNOVATION 39, printed on 29 October 2026 from databakkes.be/en/0637728676/innovation-39. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

INNOVATION 39 from Waterloo, company number BE0637728676, closed financial year 2025 with a result of € 22,570 after tax. For that financial year INNOVATION 39 recorded a gross margin of € 32,307 and equity of € 78,499. Compared with financial year 2024, the result moved from € 29,093 to € 22,570. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 18, 2026.

What it is worth Healthy

€ 78,499

▼ 40% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 22,570

▼ 22% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 11,765

▼ 32% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 74,325 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 7,788

▲ 1% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 6,241

▲ € 5,030 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 14,842

▲ 69% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 38,741 Gross margin 2022: € 38,741 First fiscal year in the series	€ 49,708 Gross margin 2023: € 49,708 ▲ 28% vs 2022 (€ 38,741) Favourable step	€ 45,549 Gross margin 2024: € 45,549 ▼ 8% vs 2023 (€ 49,708) Unfavourable step	€ 32,307 Gross margin 2025: € 32,307 ▼ 29% vs 2024 (€ 45,549) Unfavourable step	▼ 29%
Profit after taxes	€ 17,133 Profit after taxes 2022: € 17,133 First fiscal year in the series	€ 33,612 Profit after taxes 2023: € 33,612 ▲ 96% vs 2022 (€ 17,133) Favourable step	€ 29,093 Profit after taxes 2024: € 29,093 ▼ 13% vs 2023 (€ 33,612) Unfavourable step	€ 22,570 Profit after taxes 2025: € 22,570 ▼ 22% vs 2024 (€ 29,093) Unfavourable step	▼ 22%
Equity	€ 101,149 Equity 2022: € 101,149 First fiscal year in the series	€ 101,161 Equity 2023: € 101,161 Unchanged (€ 101,149) Favourable step	€ 130,254 Equity 2024: € 130,254 ▲ 29% vs 2023 (€ 101,161) Favourable step	€ 78,499 Equity 2025: € 78,499 ▼ 40% vs 2024 (€ 130,254) Unfavourable step	▼ 40%
Total debts	€ 18,045 Total debts 2022: € 18,045 First fiscal year in the series	€ 47,367 Total debts 2023: € 47,367 ▲ 162% vs 2022 (€ 18,045) Unfavourable step	€ 9,985 Total debts 2024: € 9,985 ▼ 79% vs 2023 (€ 47,367) Favourable step	€ 21,083 Total debts 2025: € 21,083 ▲ 111% vs 2024 (€ 9,985) Unfavourable step	▲ 111%
Cash	€ 5,288 Cash 2022: € 5,288 First fiscal year in the series	€ 27,275 Cash 2023: € 27,275 ▲ € 21,987 vs 2022 (€ 5,288) Favourable step	€ 17,281 Cash 2024: € 17,281 ▼ 37% vs 2023 (€ 27,275) Unfavourable step	€ 11,765 Cash 2025: € 11,765 ▼ 32% vs 2024 (€ 17,281) Unfavourable step	▼ 32%
Retained profit	€ 82,549 Retained profit 2022: € 82,549 First fiscal year in the series	€ 82,561 Retained profit 2023: € 82,561 Unchanged (€ 82,549) Favourable step	€ 111,654 Retained profit 2024: € 111,654 ▲ 35% vs 2023 (€ 82,561) Favourable step	€ 59,899 Retained profit 2025: € 59,899 ▼ 46% vs 2024 (€ 111,654) Unfavourable step	▼ 46%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 33,600 Dividend 2023: € 33,600 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 33,600) Unchanged	€ 74,325 Dividend 2025: € 74,325 Unchanged (€ 0) Unchanged
Balance sheet total	€ 119,194 Balance sheet total 2022: € 119,194 First fiscal year in the series	€ 148,528 Balance sheet total 2023: € 148,528 ▲ 25% vs 2022 (€ 119,194) Unchanged	€ 140,239 Balance sheet total 2024: € 140,239 ▼ 6% vs 2023 (€ 148,528) Unchanged	€ 99,582 Balance sheet total 2025: € 99,582 ▼ 29% vs 2024 (€ 140,239) Unchanged	▼ 29%

Key figures of INNOVATION 39, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to INNOVATION 39?

What happened at INNOVATION 39 in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 18, 2026 New annual accounts for financial year 2025: profit of € 22,570 (▼ 22% vs 2024). Source: NBB ↗
Sep 14, 2015 New establishment in Waterloo. KBO
Sep 14, 2015 Start of the company according to the CBE. KBO
2015 Eric FESLER became a director. NBB

In short

From € 17,133 profit in 2022 to € 22,570 profit in 2025.

Paid € 33,834 in corporate taxes since 2022.

Best year ever: 2023, with € 33,612 profit.

Paid out € 107,925 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Eric FESLER

INNOVATION 39

DefIMedia

AMSIT

AUDAXIS

Behind INNOVATION 39 is Eric FESLER. Eric FESLER is also behind DefIMedia, AMSIT, AUDAXIS and THE DIGITAL JOURNEY.

Directors

According to the 2025 annual accounts

Eric FESLER

Manager

Also active at: DefIMedia, AMSIT, AUDAXIS, THE DIGITAL JOURNEY

since 2015

Establishments

Establishment units

Physical locations of this company

Registered office

Drève d'Argenteuil 39

1410 Waterloo

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0637.728.676

VAT number

BE 0637.728.676

Registered office

Drève d'Argenteuil 39, 1410 Waterloo

Names & denominations

INNOVATION 39

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

14 September 2015

Peppol

Active · Active since 29 Dec 2025

Activities · NACE

Vervaardiging van meet-, controle- en navigatie-instrumenten en -apparatuur

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Installatie van industriële machines, toestellen en werktuigen

Vervaardiging van bestralingsapparatuur en van elektromedische en elektrotherapeutische apparatuur

Vervaardiging van fietsen en invalidenwagens

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

INNOVATION 39

Financials

What happened to INNOVATION 39?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions